It is well known that the commonly used antidepressant sertraline, better known under the brand name Zoloft, works well for some and not at all for others. An AI algorithm developed by researchers at Amsterdam UMC and Radboudumc in Nijmegen can now help doctors determine after a week whether a patient is sensitive to the drug, instead of the typical six to eight weeks of trial and error, the university hospitals announced.